# A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

> clinical trial · VERIFIED · 2026-08-03

Status: TERMINATED · Sponsor: Sanofi Pasteur, a Sanofi Company · Condition: RSV Immunisation

- Company: Sanofi Pasteur, a Sanofi Company
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06705140

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.